Advertisement
Screener

SAB BIOTHERAPEUTICS, INC. (SABS) Net Margin

SAB BIOTHERAPEUTICS, INC. (SABS) Net Margin

  • 2024-12-31: Net Margin -9934.52%.
  • 2024-06-30: Net Margin -2787.69%.
  • 2024-03-31: Net Margin -532.06%.
  • 2023-12-31: Net Margin -7493.75%.

Complete source-backed net margin history.

Available history
2020-12-31 to 2024-12-31
Data captured

Historical Net Margin

DateNet Margin
2024-12-31-9934.52%
2024-06-30-2787.69%
2024-03-31-532.06%
2023-12-31-7493.75%
2023-09-30-402.59%
2023-06-30-8046.13%
2023-03-31-1265.50%
2022-12-31-364.42%
2022-09-30-197.12%
2022-06-30-75.21%
2022-03-318.35%
2021-12-31-104.46%
2021-09-30-27.66%
2021-06-30-16.15%
2021-03-318.33%

Annual Net Margin

DateNet Margin
2024-12-31-2579.03%
2023-12-31-1884.50%
2022-12-31-78.40%
2021-12-31-28.16%
2020-12-3136.42%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
Liminatus Pharma, Inc. (LIMN)United States$0.282B
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
PALISADE BIO, INC. (PALI)United States$0.275B-11.41
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Ocugen, Inc. (OCGN)United States$0.343B-6.34
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05